Lenvatinib/pembrolizumab has good activity in advanced RCC, other solid tumorsJanuary 31, 2020Renal Cell CarcinomaImmuno-oncologyGenitourinary CancerMelanomaLung CancerGynecologic CancerHead & Neck/Thyroid Cancers
‘Simple’ model predicts severe neutropenia risk in lung cancer patientsJanuary 16, 2020Lung CancerLung Cancer
Sharp declines for lung cancer, melanoma deaths fuel record drop in cancer mortalityJanuary 16, 2020Lung CancerMelanomaGynecologic CancerPatient & Survivor Care
New toxicity subscale measures QOL in cancer patients on checkpoint inhibitorsJanuary 11, 2020ImmunotherapyLung CancerMelanoma
Standard-dose RT with concurrent chemo found superior for unresectable NSCLCDecember 26, 2019Lung CancerLung Cancer
Patient-reported outcomes support first-line pembrolizumab for NSCLCDecember 6, 2019Lung CancerImmuno-oncology
Single-fraction radiation just misses mark for spinal compression reliefDecember 4, 2019Breast CancerLung CancerGenitourinary Cancer
Neoantigen vaccine appears safe and active in NSCLCNovember 14, 2019Lung CancerImmunotherapyImmuno-oncology
Atezolizumab bests chemo in NSCLC patients with high PD-L1 expressionNovember 10, 2019Lung CancerImmunotherapy
